Company: BNBX
Filing Date: 2025-02-11
Form Type: DEFA14A
Source: 0001104659-25-011231
Chunk: 0

Company: BNB PLUS CORP.
Filing Date: 2025-02-11
Form: DEFA14A
Chunk 0
---
<div align='center'>UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant
to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )</div>

Filed by the Registrant x

Filed by a Party other than
the Registrant ¨

Check the appropriate box:

| ¨ | Preliminary Proxy Statement                            |
| ¨ | Confidential, for Use of                               
 the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| ¨ | Definitive Proxy Statement                             |
| x | Definitive Additional Materials                        |
| ¨ | Soliciting Material                                    
 Pursuant to §240.14a-12                                |

<div align='center'>Applied DNA Sciences, Inc.

(Name of Registrant as Specified
In Its Charter)

(Name of Person(s) Filing Proxy
Statement, if other than the Registrant)</div>

Payment of Filing Fee (Check all boxes that apply):

| x | No fee required.                                                                                     |
| ¨ | Fee paid previously with preliminary materials.                                                      |
| ¨ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. |

On February 11, 2025, Applied DNA Sciences, Inc. (the “Company”) issued the following press release, which contains information relating to the Company’s 2025 Special Meeting of Stockholders, to be held on February 14, 2025.

<div align='center'>Applied DNA Reminds Shareholders to Vote Ahead of Special Meeting on February 14</div>

STONY BROOK, N.Y.– February 11, 2025- (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in PCR-based DNA technologies, today issued a reminder to its shareholders to vote ahead of a reconvening of a Special Meeting of Stockholders (the “Special Meeting”) to be held on Friday, February 14, 2025 at 11:00 a.m.

The Company’s Board of Directors encourages any shareholder as of the record date of November 25, 2024, who has not yet voted their shares on the Warrant Exercise Proposal (as defined below), to contact Kingsdale Advisors to vote their shares: 1-855-682-9644 or by e-mail